Emergent BioSolutions Inc. (EBS)
NYSE · Healthcare
Emergent BioSolutions Inc. Total Liabilities 2009–2025
Emergent BioSolutions Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Emergent BioSolutions Inc. total liabilities as of December 31, 2025: 796.0M, a 12.23% decrease year-over-year.
- Emergent BioSolutions Inc. total liabilities for 2025 were 796.0M, a 12.23% decrease from 2024.
- Emergent BioSolutions Inc. total liabilities for 2024 were 906.9M, a 22.74% decrease from 2023.
- Emergent BioSolutions Inc. total liabilities for 2023 were 1.17B, a 34.00% decrease from 2022.
- Emergent BioSolutions Inc. total liabilities for 2022 were 1.78B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Emergent BioSolutions Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $796 |
| 2024 | $907 |
| 2023 | $1,174 |
| 2022 | $1,779 |
| 2021 | $1,346 |
| 2020 | $1,436 |
| 2019 | $1,239 |
| 2018 | $1,219 |
| 2017 | $158 |
| 2016 | $374 |
| 2015 | $377 |
| 2014 | $385 |
| 2013 | $137 |
| 2012 | $122 |
| 2011 | $130 |
Emergent BioSolutions Inc. Total Liabilities — FAQ
Emergent BioSolutions Inc. (EBS) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EBS's total liabilities history?
The chart and table above show Emergent BioSolutions Inc.'s total liabilities by year and by quarter, including the growth rate.